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Abstract 
Jeotgalicoccus sp. 8456 OleTJE (CYP152L1) is a fatty acid decarboxylase cytochrome P450 that uses 
hydrogen peroxide (H2O2) to catalyse production of terminal alkenes, which are industrially 
important chemicals with biofuel applications. We report enzyme fusion systems in which 
Streptomyces coelicolor alditol oxidase (AldO) is linked to OleTJE. AldO oxidizes polyols (including 
glycerol), generating H2O2 as a co-product and facilitating its use for efficient OleTJE-dependent fatty 
acid decarboxylation. AldO activity is regulatable by polyol substrate titration, enabling control over 
H2O2 supply to minimise oxidative inactivation of OleTJE and prolong activity for increased alkene 
production. We also use these fusion systems to generate novel products from secondary turnover 
of 2-OH and 3-OH myristic acid primary products, expanding the catalytic repertoire of OleTJE. 
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Introduction 
The Jeotgalicoccus sp. 8456 OleTJE (CYP152L1) is a member of the cytochrome P450 (P450 or CYP) 
enzyme superfamily. P450s bind heme b, which is proximally coordinated by a cysteine thiolate and 
typically has a water ligand in the 6
th
 position in the resting state (1). Substrate binding generally 
displaces the distal water ligand, converting low-spin (LS) ferric heme iron to the high-spin (HS) state 
(2). The HS heme has a more positive potential, facilitating heme iron reduction by a redox partner, 
binding of dioxygen to ferrous iron, and subsequent reduction and protonation steps resulting in 
formation of the ferryl-oxo porphyrin radical species compound I, which is the major substrate 
oxidizing species in P450s. P450s perform numerous oxidative (and other) reactions, including 
hydroxylation, demethylation, epoxidation and dehydrogenation of a vast range of substrates (3). 
However, not all P450s are redox partner-dependent. Peroxygenase P450s function efficiently using 
only hydrogen peroxide (H2O2) to drive catalysis. Early peroxygenase studies focused on P450-BSβ 
(CYP152A1) from Bacillus subtilis and P450-SPα (CYP152B1) from Sphingomonas paucimobilis. Initial 
studies suggested these enzymes were fatty acid hydroxylases, using the peroxide shunt 
mechanism to convert substrate-bound, ferric P450 directly to its ferric-hydroperoxo (compound 0) 
state, which then undergoes rapid protonation and dehydration to form compound I (4,5) (Figure 
1A). However, Rude et al. subsequently demonstrated that P450-BSβ also produced n-1 terminal 
alkenes alongside 2-OH and 3-OH fatty acids, suggesting that other CYP152 peroxygenases might 
also produce alkenes through oxidative decarboxylation of fatty acids (6). The Jeotgalicoccus OleTJE 
P450 was identified as a more efficient alkene producer, catalysing oxidative decarboxylation of fatty 
acids from ~C10-C20, generating terminal alkenes as major products, with smaller amounts of 2-OH 
and 3-OH fatty acids (6,7). Terminal alkenes have industrial uses in plastics, lubricants and as 
feedstocks for other compounds, e.g. alcohols and surfactants (8). Alkenes are also potential fuels, 
making OleTJE an attractive candidate for production of drop-in biofuels (9). 
The structure and catalytic mechanism of OleTJE have been characterized (10-12), revealing how the 
fatty acid carboxylate binds close to the P450 heme (Figure 1B), as well as the different mechanisms 
by which OleTJE produces alkenes and hydroxylated fatty acids. OleTJE was reported to catalyse 97% 
conversion of 200 µM myristic acid (C14:0) in the presence of 500 µM H2O2 (7). However, on an 
industrial scale excess H2O2 may inhibit enzymatic activity (13). This phenomenon was demonstrated 
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in the Clostridium actetobutylicum peroxygenase P450 CLA (CYP152A2) where, despite high 
peroxygenase activity (200 min
-1
) with myristic acid, use of 200 µM H2O2 caused enzyme inactivation 
in 2-4 minutes (14). Also, using H2O2 in a bacterial cell-based alkene-producing system may not be 
viable, as H2O2 levels of only 2 µM can cause growth inhibition of E. coli (15). Girhard et al. described 
a novel method of driving peroxygenases, using light to excite flavin cofactors with 
ethylenediaminetetraacetic acid (EDTA) as an electron donor. Electron transfer from reduced flavins 
then converts dioxygen to H2O2. The approach was successful with P450 CLA and P450 BSɴ, where 
near-complete conversion of 200 µM myristic acid was observed using flavin mononucleotide (FMN) 
(16). This method also worked with OleTJE, where 99% of stearic acid (C18:0) substrate was oxidised, 
a much higher conversion rate than achieved by direct H2O2 addition either at the start of the 
process, or stepwise during the reaction (13). However, this light driven approach produced low 
conversion levels for the shorter chain substrates lauric acid (C12:0) and myristic acid (13). 
In this manuscript, we present novel alkene-producing systems in which the H2O2-forming alditol 
oxidase (AldO) from Streptomyces coelicolor is fused to OleTJE. AldO is a 45.1 kDa flavoprotein 
containing covalently bound flavin adenine dinucleotide (FAD) (17). AldO catalyses oxidation of the 
primary alcohol moiety of alditols using molecular oxygen, and forms the aldose product and H2O2. 
AldO oxidizes several polyol substrates, including glycerol, sorbitol and diols such as 1,2-propanediol 
and 1,2-hexanediol (18). Our rationale for creating the OleTJE-AldO fusion is that the H2O2 coproduct 
from AldO should drive fatty acid decarboxylation by OleTJE and that the system could be regulated 
through measured alditol substrate additions to maintain H2O2 concentrations compatible with 
efficient substrate conversion, while minimising heme destruction by excess H2O2. We present 
catalytic data showing the efficiency of the reactions, as well as using OleTJE and AldO fusion systems 
to identify novel products of OleTJE-dependent fatty acid oxidation. 
 
Materials and Methods 
Gene Cloning 
The OleTJE (CYP152L1) gene from Jeotgalicoccus sp 8456 was codon optimised for expression in E. 
coli, synthesised (Genscript, Cherwell UK) and cloned into pET15b at NdeI/BamHI sites. The construct 
contains an N-terminal polyhistidine tag and a TEV cleavage site 5 to the NdeI cleavage site. The 
alditol oxidase (AldO) gene from Streptomyces coelicolor A3(2) with an N-terminal polyhistidine tag 
and TEV cleavage site was codon optimised for E. coli expression and synthesised (Genscript), prior 
to cloning into pET24b at NdeI/BamHI sites. 
Cloning of the OleTJE-HRV3C-AldO fusion protein gene construct (linker sequence: 
GSGLEVLFQGPGSGGGGS with cleavage site underlined) was performed by amplification of 
OleTJE/AldO genes from pET15b/pET24b plasmids using primers OleTJE-For: 
GTATTTCCAAGGCCATATG, OleTJE-Rev: CCCCTGGAACAGAACTTCCAGACCAGAACCGGTGCGGTC 
CACAAC, AldO-For: GAAGTTCTGTTCCAGGGGCCCGGATCTGGCGGCGGC, and AldO-Rev: 
ATTGCGGATCCTTATCAGCCGGCCAG using Phusion High Fidelity DNA polymerase (NEB, Hitchin UK). 
The 5-OleTJE and AldO-3 genes were then joined with an HRV3C cleavage site by PCR using primers 
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GTATTTCCAAGGCCATATG and ATTGCGGATCCTTATCAGCCGGCCAG, respectively. The OleTJE-HRV3C-
AldO gene was then cloned into the pET15b-TEV plasmid at NdeI/BamHI sites (Figure 2). 
The OleTJE-αhelix-AldO construct was produced using a NEB HiFi DNA assembly Kit (NEB) according 
to manufacturers instructions. DNA encoding the A(EAAAK)4LEA(EAAAK)4A α-helix was synthesised 
(Eurofins, Manchester UK). The pET15b OleTJE-HRV3C-AldO plasmid was used as a template, and 
primers ATGTCGGATATTACCGTTACG and GGTGCGGTCCACAACTTC were used to amplify the 
backbone. The α-helix insert was amplified with backbone overhangs of 15 bp using primers 
GTTGTGGACCGCACCGCTGAGGCTGCCGCTAAG and ACGGTAATATCCGACATCGCTTTTGCTGCTGCTTC 
(Figure 2). 
 
Gene expression and protein purification 
The pET15b-OleTJE, pET15b-OleTJE-HRV3C-AldO and pET15b-OleTJE-αhelix-AldO plasmids were 
transformed into E. coli C41 (DE3) and grown in 500 ml 2xYT cultures. Cultures were shaken at 200 
rpm at 37°C until an OD600 of 0.5. 500 µM ɷ-aminolevulinic acid (ΔALA) was added and gene 
expression induced with 100 µM isopropyl 1-thio-ß-D-galactopyranoside (IPTG). Temperature was 
decreased to 25°C for pET15b-OleTJE transformed cells, and to 20°C for cells transformed with 
pET15b-OleTJE-HRV3C-AldO and pET15b-OleT-αhelix-AldO constructs. Cells were grown for a further 
20 hours before harvesting by centrifugation at 6000 rpm at 4°C in a JLA-8.1 rotor using an Avanti J-
26 XP centrifuge. Cell pellets were washed with ice-cold 100 mM KPi buffer (pH 8), centrifuged again 
and stored at -80°C until required for purification. 
 
Purification of OleTJE, OleTJE-HRV3C-AldO, OleTJE-αhelix-AldO and P450 BM3 heme domain 
OleTJE expressing cells were resuspended in 100 mM KPi, 1 M NaCl, 10% glycerol (pH 8) (buffer A). 
OleTJE-HRV3C-AldO and OleTJE-αhelix-AldO expressing cells were resuspended in 100 mM KPi, 750 
mM NaCl (pH 8) (buffer B). To each cell suspension, SigmaFAST Protease Inhibitor Cocktail Tablets 
(EDTA-Free), 100 µg/ml DNase I and lysozyme were added (Sigma-Aldrich, Poole UK). Cell 
suspensions were sonicated for 40 minutes at 10 s on, 50 s off, at 40% amplitude using a Bandelin 
Sonopuls sonicator. The cell homogenate was then centrifuged at 20,000 rpm for 90 minutes at 4°C 
using a JA-25.5 rotor. 
For OleTJE, 5 mM imidazole and nickel-iminodiacetic acid (Ni-IDA) chromatographic medium 
(Generon, Maidenhead UK) (10 ml/100 g cell pellet) was added to the supernatant and stirred 
overnight at 4°C. The resin was packed into a column, washed with 20 column volumes (CV) of 50 
mM imidazole in buffer C (100 mM KPi, 750 mM NaCl, 10% glycerol [pH 8]) and the flow-through 
collected. After washing with 2 CV of 150 mM imidazole in buffer C, OleTJE protein was eluted in 175 
mM imidazole in buffer C and extensively dialysed into buffer C to remove imidazole and fatty acids 
retained from E. coli. OleTJE was concentrated using a Vivaspin (30,000 MWCO, GE Healthcare, Little 
Chalfont UK) and transferred into 100 mM KPi, 750 mM NaCl, 20% glycerol (pH 8) (buffer D) using a 
PD10 Desalting Column (GE Healthcare). The protein was then flash frozen in liquid nitrogen and 
stored at -80°C. 
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For OleTJE-HRV3C-AldO and OleTJE-αhelix-AldO, 5 mM imidazole and Ni-IDA (5 ml/100 g) was added 
to cell supernatants and samples stirred at 4°C for 2 hours. The resin was washed using 20 CV of 50 
mM imidazole in buffer B and the flow-through retained. Proteins were eluted with 250 mM 
imidazole in buffer B, and incubated overnight at 4°C with ~500 U of a S219V TEV protease variant 
(expressed using plasmid pRK793, Addgene plasmid no 8827) (19). The protein was exchanged into 
buffer B using a desalting column, and added to a bed of Ni-IDA resin. His-tag cleaved protein was 
eluted with 20 mM imidazole in buffer B, concentrated using a Vivaspin (30,000 MWCO) and 
exchanged into buffer B using a PD10 desalting column. Aliquots were frozen in liquid nitrogen and 
stored at -80°C. 
The Bacillus megaterium P450 BM3 heme domain (BM3) and Mycobacterium tuberculosis CYP51B1 
and CYP121A1 P450s were expressed and purified as described previously (20-22). 
 
Hydrogen peroxide tolerance of P450 enzymes 
UV-visible spectroscopy was done on a Cary 60 UV-visible spectrophotometer (Agilent, Cheadle UK). 
Oxidative modification of OleTJE and other P450 hemes was measured at H2O2 concentrations of 25, 
50, 75, 125, 250, 500, 1000 and 2000 µM in buffer C. Stock H2O2 concentrations were prepared at 
500x final concentration. After H2O2 addition, P450 spectra were recorded every 1.5 minutes for 1 
hour at 10°C. Soret peak intensity (418 nm for OleTJE and CYP51B1, 419 nm for BM3, and 417 nm for 
CYP121A1) was plotted against time. In each case, data were fitted accurately using a single 
exponential decay function. 
 
In vitro substrate turnover reactions with fusion proteins 
Reactions were done in buffer B. To cleave OleTJE-HRV3C-AldO, HRV3C (Novagen, Feltham UK) was 
added at 1 U/100 µg OleTJE-HRV3C-AldO, and incubated for 1 hour at 4°C. Proteins were exchanged 
into buffer B using a PD10 desalting column before starting reactions.  
For reactions with OleTJE-HRV3C-AldO and OleTJE-αhelix-AldO, 0.5 ml reactions contained 5 µM 
enzyme, 500 µM myristic acid and varying concentrations of different AldO substrates. Initial studies 
tested glycerol (3%, 1%, 0.1% and 0.01%), xylitol (2 mM and 10 mM) and sorbitol (2 mM and 10 
mM). Reactions were incubated for 20 minutes. Time dependence studies were also done using 1% 
glycerol at time points of 0.5, 1, 2, 5, 10, 20 and 30 minutes. Additional reactions were done with 
0.1% and 0.01% glycerol with incubations for 20 minutes. Time point experiments and reactions with 
0.1% and 0.01% glycerol were done in duplicate with incubation at 27°C and shaking at 700 rpm, 
using 5 µM enzyme and 500 µM myristic acid in a 0.5 ml volume. 
Reactions were stopped with 20 µl of 37% HCl. Internal standards 1-pentadecene, palmitic acid 
(C16:0), 2-OH palmitic acid and 3-OH palmitic acid were added, and reactions were extracted with an 
equal volume of dichloromethane (DCM). The DCM layer was removed and dried with anhydrous 
MgSO4. DCM extract was mixed with an equal volume of N,O-bis(trimethylsilyl)trifluoroacetamide 
(BSTFA) containing 1% trimethylchlorosilane (TMCS) and incubated at 60°C for 45 minutes to 
derivatise fatty acids. 
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In vitro OleTJE enzymatic reactions with products 
To investigate OleTJEs ability to further oxidize initial reaction products, 200 µM 1-tridecene, 200 
µM α-OH myristic acid or 200 µM β-OH-myristic acid was incubated with either (i) 1 µM OleTJE/500 
µM H2O2 or (ii) 5 µM OleTJE-HRV3C-AldO/1% glycerol. Reaction mixtures were incubated for 30 
minutes at 27°C before acidification with 20 µl 37% HCl, and extraction, drying and derivatisation as 
described previously. 
 
GC/Q-TOF 
After derivatisation, 1 µl of sample was injected onto an Agilent 7200 GC/QTOF with 7890B GC, 
installed with a VF-5ms 30 m x 250 mm x 0.25 mm column. The front inlet was set at 250°C, and a 
split ratio of 25:1 was used. Column flow was set at 1.2 ml/min, and the oven was held at 100°C for 1 
minute before being ramped at 25°C/min until 200°C. Ramping was decreased to 15 ml/min until 
325°C, and held for 2 minutes. Electronic ionization was used, and m/z ratios of 40-500 were 
recorded at 5 Hz and at 230°C. Quantitation of tridecene, myristic acid, α-OH myristic acid and β-OH 
myristic acid was performed using external standard calibration curves and structural analogue 
internal standards. 
 
Fusion protein kinetics 
To determine reaction kinetics for (i) OleTJE-αhelix-AldO and (ii) intact and cleaved forms of OleTJE-
HRV3C-AldO, decreases in myristic acid substrate concentration were plotted against reaction time. 
Data were fitted using a single exponential function. 
Results 
 
Hydrogen peroxide tolerance 
The peroxygenase OleTJE uses H2O2 to drive fatty acid decarboxylation. However, excess H2O2 
oxidatively damages heme and protein. To investigate this phenomenon, H2O2 was added to OleTJE 
at various concentrations from 25-12000 µM, and decreases in Soret peak intensity were monitored. 
To compare effects of H2O2 on OleTJE with other P450s, the experiment was repeated with the fatty 
acid hydroxylase P450 BM3 heme domain (BM3), and the M. tuberculosis P450s CYP51B1 (sterol 
demethylase) and CYP121A1 (cyclodipeptide oxidase) (20-22). Heme modification was measured at 
intervals up to one hour, and at 10°C to minimise temperature-related effects on protein stability 
(Table 1). Figure 3 shows time-dependent changes in UV-visible spectra for OleTJE and the other 
P450s, demonstrating Soret band absorbance decreases indicative of heme modification. Decreases 
in P450 Soret peak intensity were plotted against time, and rate constants (k) were derived for heme 
oxidation processes. For OleTJE, BM3, CYP51B1 and CYP121A1, data were fitted using a single 
exponential function. The heme oxidation rate constant (k) is consistently lower for OleTJE compared 
to the other P450s. Differences in H2O2 tolerance are most apparent at higher H2O2 concentrations 
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(e.g. k = 8.51 min
-1
 for OleTJE compared to 43.25 min
-1
 for BM3). Moreover, heme oxidation 
progresses much further for the other P450s than for OleTJE over the same time frame. These data 
demonstrate that OleTJE has a greater H2O2 tolerance than the other bacterial P450 
monooxygenases, consistent with its function as a peroxygenase. Some OleTJE heme depletion 
clearly occurs at 1 mM H2O2, and peroxide concentrations in this range are typically used in 
peroxygenase turnover experiments with fatty acids (10,23). However, more efficient fatty acid 
oxidation (with less heme destruction) could be achieved in a catalytic system where H2O2 is 
produced (and enzymatically consumed) continuously at a level that is non-destructive to OleTJE 
heme. 
 
Construction of OleTJE-HRV3C-AldO and OleTJE-αhelix-AldO fusion proteins 
Two fusion proteins (OleTJE-HRV3C-AldO and OleTJE-αhelix-AldO) were constructed by linking OleTJE 
to S. coelicolor AldO. In these systems, AldO produces H2O2 from oxidation of substrates including 
glycerol, sorbitol and xylitol. H2O2 then drives fatty acid decarboxylation by OleTJE. The OleTJE-HRV3C-
AldO fusion contains a short peptide linker incorporating a HRV3C cleavage site. The protease 
cleavage site enables production of stoichiometric amounts of free OleTJE and AldO, allowing for 
comparative analysis of the activity of the separated enzymes. The OleTJE-HRV3C-AldO protein was 
produced at ~2.5 mg/L culture. Fusing human growth hormone (hGH) and transferrin (Tf) with a rigid 
helical linker was shown to be more successful for protein production by comparison to hGH/Tf 
fusions without a helical linker (24,25). We adopted a similar strategy to produce the OleTJE-αhelix-
AldO fusion enzyme, which was also purified at ~2.5 mg/L. Figure 4 shows SDS-PAGE gels of both 
constructs following purification by Ni-IDA chromatography, TEV cleavage of the polyhistidine tag, 
and separation of the untagged fusion protein by reverse Ni-IDA chromatography. Figure 4A also 
shows OleTJE-HRV3C-AldO following inter-domain cleavage using HRV3C protease. 
 
Driving fatty acid decarboxylation with different AldO substrates 
Reactions were set up with 5 µM OleTJE-HRV3C-AldO, 0.5 mM myristic acid and different AldO 
substrates (glycerol, sorbitol and xylitol). An additional reaction was set up with 500 µM H2O2 and 5 
µM OleTJE-HRV3C-AldO. A control reaction without substrate was also set up, including 40 units of 
catalase to remove any H2O2. Table 2 shows that all AldO substrates gave high levels of turnover, 
facilitating myristic acid oxidation levels of 91-95%, compared to 87% in the case where H2O2 was 
added directly to substrate-bound OleTJE. Glycerol gave marginally the highest levels of substrate 
oxidation, and was used as the AldO substrate in further experiments. 
 
Time-dependent oxidation of fatty acids using fusion proteins 
Reactions were set up with 1% glycerol, 0.5 mM myristic acid, and 5 µM of (i) intact OleTJE-HRV3C-
AldO, (ii) cleaved OleTJE-HRV3C-AldO or (iii) OleTJE-αhelix-AldO. Myristic acid concentration was 
plotted against time, and rate constants (k) determined for fatty acid conversion. The highest rate 
was obtained for OleTJE-αhelix-AldO (0.48 ± 0.02 min
-1
). OleTJE-HRV3C-AldO and the HRV3C-cleaved 
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forms showed conversion rates of 0.38 ± 0.05 min
-1
 and 0.15 ± 0.01 min
-1
, respectively, indicating 
that the fused enzymes have higher activity than their separate entities at the same concentration. 
Figure 5 shows GC-MS analysis of myristic acid products formed by the OleTJE-αhelix-AldO fusion 
enzyme. 
Product formation over time was also monitored for the conditions (i)-(iii). In all cases, tridecene was 
the major product after 20 minutes (Table 3). However, for both intact and cleaved OleTJE-HRV3C-
AldO, 3-OH myristic acid is initially produced at high levels, and is the major product at 1 minute. 
Levels of 2-OH and 3-OH myristic acid decreased after 2 minutes in all three conditions. We 
hypothesised that, with continued production of H2O2 by AldO-dependent glycerol oxidation, the 
hydroxylated fatty acids are further converted into other products. This finding indicates that the 
OleTJE protein constructs used remain active throughout the assays and can bind and further oxidise 
the primary reaction products. 
 
Optimising glycerol concentration for OleTJE activity 
To establish suitable glycerol concentrations for OleTJE-AldO fusion proteins, reactions were also 
performed with 0.1 and 0.01% glycerol, and stopped after 20 minutes. Table 3 compares the 
percentage conversion of myristic acid for (i) intact OleTJE-HRV3C-AldO, (ii) cleaved OleTJE-HRV3C-
AldO, and (iii) OleTJE-αhelix-AldO, as well as the concentrations of tridecene, 2-OH myristic acid and 
3-OH myristic acid products formed. For all proteins, there was little activity at 0.01% glycerol. 
However, hydroxylated products were formed at higher levels than alkene at low glycerol 
concentrations. At 0.1% glycerol, levels of 2-OH and 3-OH myristic acid are higher than at 1% 
glycerol. This may occur due to limited enzymatic activity at the lower glycerol concentration, 
resulting in less efficient secondary oxidation of the primary hydroxylated reaction products. 
For intact OleTJE-HRV3C-AldO, the 1% glycerol condition yielded a 15% increase in total turnover and 
9% increase in alkene production compared to 0.1% glycerol. There was little difference in total 
turnover and alkene levels for the intact and HRV3C-cleaved forms of OleTJE-HRV3C-AldO, suggesting 
that proteolytic cleavage is effective and does not inactivate enzymatic functions. 
 
Secondary turnover of 2-OH myristic acid and 3-OH myristic acid products 
Time-course reactions with OleTJE-AldO fusion proteins showed that levels of 2-OH and 3-OH 
myristic acid decreased over time (from ~2 minutes onwards). This suggested that OleTJE can convert 
these hydroxylated fatty acids to further products (Figure 6). 0.5 ml reactions were set up with 5 µM 
OleTJE-HRV3C-AldO, 1% glycerol and 200 µM of either 2-OH or 3-OH myristic acid, or using 1 µM 
OleTJE/500 µM H2O2. Previous studies on the S. coelicolor AldO enzyme reported a kcat = 17 s-1 and a 
kcat/Km = 1.2 x 10
4
 M
-1
 s
-1
 for sorbitol, and values of kcat = 13 s
-1
 and kcat/Km = 4.1 x 10
4
 M
-1
 s
-1
 for xylitol 
at pH 7.5 (26); and a kcat/Km = 2.1 x 10
4
 M
-1
 s
-1
 for glycerol at pH 9.0 (27). Given the similar extents of 
oxidation of these different substrates by the OleTJE-HRV3C-AldO fusion enzyme (Table 2), it is likely 
that the kinetics of this fusion enzyme are similar to those reported previously. 
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Reactions were incubated for 30 minutes with mixing at 700 rpm at 27°C. GC/Q-TOF chromatograms 
were compared to those of control samples without enzyme. Data showed that both 2-OH and 3-OH 
myristic acid were used effectively as OleTJE substrates, with 3-OH myristic acid reactions showing 
almost complete turnover (Figure 7). For the 2-OH myristic acid reaction, two products were 
identified. One of these products is tridec-1-en-1-ol, indicating that OleTJE can decarboxylate 2-OH 
myristic acid. The ion spectrum of the second product indicates that it is 2-hydroxytetradec-2-enoic 
acid. This demonstrates that OleTJE can desaturate 2-OH myristic acid at the Cα-Cβ bond. For 
reactions with 3-OH myristic acid, the product is 3,4 dihydroxytetradec-2-enoic acid, indicating that 
OleTJE can further hydroxylate as well as desaturate 3-OH myristic acid. 
 
Discussion 
The Jeotgalicoccus sp. OleTJE is an efficient P450 peroxygenase that uses H2O2 to oxidatively 
decarboxylate fatty acids to form terminal alkenes. This peroxide shunt mechanism (Figure 1) to 
form compound 0 is inefficient in many P450s, including BM3, causing heme oxidative damage and 
giving low product formation. Efforts have been made to enhance peroxide shunt efficiency through 
protein engineering of BM3 and the camphor hydroxylase P450cam, although improvements were 
not substantial (28,29). Our data (using heme stability analysis) show that OleTJE is relatively tolerant 
to H2O2, and clearly more resistant to H2O2-mediated heme oxidation than are the BM3, CYP121A1 
and CYP51B1 P450s (Figure 3, Table 1). Even after incubation of OleTJE with 1 mM H2O2, its Fe
II
-CO 
spectrum remains almost completely in the P450 (Amax = 449 nm) form, indicative of negligible loss 
of its cysteine thiolate heme ligand. However, despite its evolution into a peroxygenase, it remains 
somewhat susceptible to heme modification at higher concentrations of H2O2 (e.g. 1-2 mM), 
although the enzyme should not encounter such elevated levels of H2O2 in the bacterial cell. 
In this study, we report the production and catalytic properties of AldO-OleTJE fusion systems. AldO 
produces H2O2 as a co-product from oxidation of substrates including glycerol, sorbitol and xylitol. 
The fused OleTJE uses the H2O2 to drive decarboxylation and hydroxylation of myristic acid, a good 
substrate for OleTJE (7). In a system where OleTJE and AldO proteins are fused by a linker containing a 
HRV3C cleavage site (OleTJE-HRV3C-AldO), addition of 1% glycerol gave an 8% increase in myristic 
acid conversion compared to addition of 0.5 mM H2O2 (following a 20 minute incubation). Glycerol is 
abundant and inexpensive (30), and is formed as a by-product in the production of biofuels, with 
associated disposal costs (31). Glycerol would thus be an ideal substrate for cheap and efficient 
alkene production using AldO-OleTJE fusion enzymes. 
The kinetics of myristic acid oxidation and product formation were measured for (i) OleTJE-HRV3C-
AldO, (ii) OleTJE-αhelix-AldO, a construct in which OleTJE and AldO are fused by a non-cleavable alpha 
helical linker, and (iii) the separated OleTJE and AldO entities produced stoichiometrically by HRV3C-
dependent cleavage of the OleTJE-HRV3C-AldO linker. The fused proteins showed higher rates of 
myristic acid turnover than their separated entities, with 97% myristic acid turnover catalysed by 
OleTJE-αhelix-AldO after 20 minutes. Fusion of partner domains thus enhances product formation in 
comparison to equal amounts of isolated OleTJE and AldO. The ability to co-express functional and 
stable OleTJE/AldO fusion enzymes is also advantageous in producing catalytically self-sufficient 
enzymes. The proximity of these domains in the fusion enzymes may enhance activity through more 
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efficient channelling of H2O2 between the enzyme active sites, and in a cellular context this could be 
important in ensuring that fatty acid decarboxylation/hydroxylation is well coupled to H2O2 
production. The regulated and continuous glycerol-dependent production of H2O2 from the 
OleTJE/AldO fusion enzymes described here is likely conducive to more efficient fatty acid oxidation. 
Previous studies of bacterial peroxygenases have also used such continuous H2O2 production 
strategies (e.g. a light-driven H2O2-producing system) (13,32). Our ongoing studies involve analysis of 
product formation from the OleTJE-AldO fusion enzymes expressed in E. coli cells to establish 
reaction efficiency and products formed. 
Importantly, time-dependent studies of myristic acid product formation from OleTJE-AldO fusion 
enzymes indicated the early formation and then decrease in concentration of 2-OH and 3-OH 
myristic acid products. Reactions done at lower glycerol concentration (0.1%) produced higher levels 
of hydroxylated myristic acid, possibly due to decreased levels of secondary turnover of the 
hydroxylated products through weaker enzyme activity at lower glycerol concentrations. Incubation 
of 2-OH myristic acid with OleTJE/H2O2, or with OleTJE-HRV3C-AldO and 1% glycerol, led to further 
turnover of 2-OH myristic acid and formation of 2-hydroxytetradec-2-enoic acid and tridec-1-en-1-ol, 
indicating that OleTJE can decarboxylate 2-OH myristic acid as well as catalysing desaturation of this 
substrate. Desaturation reactions are among the wide repertoire of molecular transformations 
catalysed by P450s. These may occur either due to (i) imperfect positioning of the substrate carbon 
radical that forms following hydrogen abstraction to form P450 compound II (Fe
IV
-OH), leading to an 
electron transfer from the carbon radical to the iron, forming a carbocation. Loss of the proton 
adjacent to the carbocation then results in double bond formation; or (ii) compound II not 
recombining with the substrate carbon radical, and instead abstracting a hydrogen atom from a 
carbon adjacent to the radical to form the double bond (33). Parallel reactions also revealed 
extensive conversion of 3-OH myristic acid, and formation of 3,4 dihydroxytetradec-2-enoic acid. 
These data demonstrate that OleTJE can di-hydroxylate the fatty acid, in addition to desaturating the 
Cα-Cβ bond. OleTJE was previously shown to produce 2-alkanones from reactions with palmitic acid 
and stearic acid (C16:0 and 18:0) (34). However, we provide the first examples for the secondary 
turnover of primary OleTJE reaction products with myristic acid. 
In conclusion, we describe the development of novel alditol oxidase-peroxygenase (AldO-OleTJE) 
fusion enzymes that enable production of alkenes using glycerol and other alditol substrates. 
Further, we use these fusion systems to characterize previously undescribed decarboxylated, 
hydroxylated and desaturated products formed from primary reaction products (2- and 3-hydroxy 
myristic acid). These data provide new insights into the catalytic repertoire of OleTJE, as well as 
providing efficient new fusion enzyme systems for alkene production. 
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FIGURES 
Figure 1. P450 catalytic cycle and active site structure of OleTJE. Panel A shows a cytochrome P450 
catalytic cycle, illustrating how OleTJE utilises the peroxide shunt pathway to catalyse fatty acid 
decarboxylation to form terminal alkenes. In its ferric resting state, the OleTJE heme iron is axially co-
ordinated by cysteine thiolate and a water molecule. Upon addition of fatty acid (a), the axial water 
molecule is displaced, and the heme iron converts from a low spin (LS) to a high spin (HS) state (2). 
Addition of H2O2 to OleTJE initiates the peroxide shunt, forming a ferric-hydroperoxo intermediate 
(Compound 0, reaction indicated by the arrow crossing the cycle). Protonation and dehydration of 
Compound 0 (f), yields a reactive ferryl (Fe
IV
)-oxo, porphyrin radical cation (Compound I), which has 
been observed in OleTJE using single turnover stopped-flow absorption spectroscopy (11). OleTJE 
then catalyses either decarboxylation of the fatty acid (g-i) to form terminal alkene (the major 
reaction), or hydroxylates the substrate at the α- or β-position (not shown). Hydroxylation involves 
Compound I-mediated hydrogen abstraction from a substrate CH group (forming Compound II, Fe
IV
-
OH), and hydroxylation by radical rebound with restoration of the ferric heme (35). However, 
decarboxylation likely occurs through the further abstraction of an electron from the substrate 
radical by Compound II (h), producing an unstable substrate carbocation or diradical that 
decarboxylates to generate the alkene (12). The alkene product then dissociates, releasing CO2 (i), 
and a protonation step restores the ferric heme iron to its resting, water ligated form. OleTJE can also 
function using redox partner systems, in which case two electron transfer steps and one protonation 
step are required to convert the substrate-bound, ferric species to compound 0 [(b)-(e)] (34,36). 
Steps (f)-(i) then occur as described above following the peroxide shunt process (3). Panel B shows 
the active site of OleTJE bound to arachidic acid (C20:0), with substrate shown in orange (10) (PDB 
4L40). The heme is coloured in blue, and is proximally coordinated to Cys365 thiolate. Also shown is 
arachidic acid (orange) and the interaction between its carboxylate and Arg245. 
Figure 2. Schematic of OleTJE-AldO constructs. Panel A shows how an OleTJE-AldO fusion system can 
use S. coelicolor AldO to oxidise glycerol (or another alditol substrate), forming H2O2 as a co-product. 
H2O2 is then used by OleTJE to decarboxylate fatty acids such as myristic acid, producing terminal 
alkenes as the major product. Terminal alkenes have important potential industrial uses, including as 
drop-in biofuels. Panel B shows the fusion constructs used in this work. (i) OleTJE-HRV3C-AldO. 
OleTJE and AldO are fused by a HRV3C-cleavable linker, enabling stoichiometric production of OleTJE 
and AldO, as shown in (ii). (iii) OleTJE-αhelix-AldO. In this construct OleTJE and AldO are linked by an 
A(EAAK)4LEA(EAAK)4A α-helix. 
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Figure 3. P450 H2O2 tolerance. Panels A-D show the UV-visible spectra of OleTJE (A), BM3 heme 
domain (B), CYP51B1 (C), and CYP121A1 (D), before (thick solid line) and after the addition of 1 mM 
H2O2. Proteins are all at a concentration of 5 µM. These spectra show heme absorbance decrease 
due to H2O2-mediated oxidation of the prosthetic group, sampled over 1 hour at 1.5 minute 
intervals. Rate constants for heme oxidation were obtained for the four proteins at H2O2 
concentrations between 0.025-2 mM H2O2 (see Table 1). At 1 mM H2O2, the greater stability of OleTJE 
enzyme compared to the other (non-peroxygenase) P450s is clear, with much greater heme 
oxidation and absorbance loss observed for BM3 heme domain, CYP51B1 and CYP121A1 compared 
to OleTJE under the same conditions.  
Figure 4: SDS-PAGE analysis of purified OleTJE fusion proteins. Panel A shows intact OleTJE-HRV3C-
AldO (i) and cleaved OleTJE-HRV3C-AldO (ii), following incubation of the fusion protein with HRV3C 
protease for 1 hour at 4°C. Panel B shows purified OleTJE-αhelix-AldO (iii). Samples were resolved by 
SDS-PAGE using a 10% polyacrylamide gel. The first lane in each case shows protein markers (NEB 
Broad Range Protein Ladder). 
Figure 5: GC/MS chromatogram showing products formed by the OleTJE-αhelix-AldO fusion protein 
with myristic acid substrate. The reaction shown was performed at 27°C with shaking at 700 rpm, 
and with 0.5 mM myristic acid, 5 µM OleTJE-αhelix-AldO fusion protein and 0.1% glycerol. The black 
chromatogram shows reaction products formed with the reaction stopped at 20 minutes. The red 
chromatogram shows a control reaction containing the same components, but also including 
catalase (40 units) to remove H2O2. The peaks relate to the following compounds: i) tridecene, ii) 
pentadecene (internal standard), iii) myristic acid, iv) 2-OH myristic acid, v) 3-OH myristic acid, and 
vi) palmitic acid (internal standard). 
Figure 6. Time dependence of myristic acid conversion and product formation at 1% glycerol. 
Panels A, B and C show the extents of myristic acid conversion using GC/MS data collected following 
stopping the reaction immediately after its initiation (~10 s), and then after 0.5, 1, 2, 5, 10 and 20 
minutes for intact OleTJE-HRV3C-AldO, cleaved OleTJE-HRV3C-AldO and OleTJE-αhelix-AldO, 
respectively. Panels D, E and F show concentrations of tridecene, 2-OH myristic acid and 3-OH 
myristic acid in samples taken over 20 minutes for the same enzymes. Duplicate samples were 
tested and standard errors are shown. 
 
Figure 7. Secondary turnover of primary hydroxylated products from OleTJE-HRV3C-AldO fusion 
protein-mediated myristic acid oxidation. Panel A shows chromatograms from a reaction (black) 
with 5 µM OleTJE-HRV3C-AldO fusion protein, 200 µM 2-OH myristic acid and 500 µM H2O2, as well 
as a control sample with no enzyme (red). The reaction shows a decrease in 2-OH myristic acid (ii) 
and the appearance of peaks (i) and (iii). The ion spectra identify these molecules as (i) tridec-1-en-1-
ol and (iii) 2-hydroxytetradec-2-enoic acid. Panel B shows reaction (black) and control (red) with 200 
µM 3-OH myristic acid (same conditions as for panel A). The data show the disappearance of 3-OH 
myristic acid (iv), and the appearance of peak (v), which is identified as 3,4 dihydroxytetradec-2-
enoic acid. 
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Table 1. Rates of oxidative modification of OleTJE, P450 BM3 heme domain, CYP51B1 and 
CYP121A1 by H2O2. Rate constants for heme oxidation (k) and associated absorbance amplitudes (A) 
for heme Soret peak absorption change are presented for OleTJE (418 nm), BM3 heme domain (419 
nm), CYP121A1 (417 nm) and CYP51B1 (418 nm) across a range of H2O2 concentrations. Data were 
fitted using a single exponential function. ND indicates that rate constants could not be determined 
accurately due to small amplitudes of heme absorbance change at the lowest concentrations of H2O2 
or (in the case of CYP51B1 and H2O2 concentrations of 0.125 and 0.075 mM) due to linearity of the 
progress curve. 
 
H2O2 
(mM) 
OleTJE BM3 CYP51B1 CYP121A1 
 k (min
-1
) A k (min
-1
) A k (min
-1
) A k (min
-1
) A 
2 
8.51 ± 
0.17 
0.182 ±  
0.001 
43.25 ± 
0.26 
0.315 ± 
0.002 
16.14 ± 
0.23   
0.269 ± 
0.004 
26.94 ± 
0.23 
0.221 ± 
0.002 
1 
6.99 ± 
0.16 
0.065 ± 
0.001 
22.15 ± 
0.17 
0.284 ± 
0.002 
13.84 ± 
0.15 
0.236 ± 
0.009 
16.29 ± 
0.18 
0.193 ± 
0.001 
0.5 
5.65 ± 
0.14 
0.043 ± 
0.001 
17.36 ± 
0.11 
0.257 ± 
0.002 
10.07 ± 
0.11  
0.131 ± 
0.007 
14.36 ± 
0.16 
0.203 ± 
0.001 
0.25 
4.96 ± 
0.13 
0.029 ± 
0.001 
12.60 ± 
0.16 
0.199 ± 
0.002  
6.79 ± 
0.21 
0.058 ± 
0.013 
9.38 ± 
0.11 
0.138 ± 
0.001 
0.125 
5.38 ± 
0.14 
0.021 ± 
0.001 
9.08 ± 
0.11 
0.103 ± 
0.001 
ND ND 
6.96 ± 
0.08 
0.077 ± 
0.001 
0.075 
5.94 ± 
0.12 
0.018 ± 
0.001  
7.23 ± 
0.08 
0.062 ± 
0.001 
ND ND 
5.34 ± 
0.08 
0.023 ± 
0.001 
0.05 ND ND 
4.36 ± 
0.06 
0.040 ± 
0.001 
ND ND 
2.16 ± 
0.05 
0.013 ± 
0.001 
0.25 ND ND ND ND ND ND ND ND 
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Table 2. OleTJE-dependent oxidation of myristic acid with different substrates. The percentage 
conversion of 0.5 mM myristic acid by the OleTJE-HRV3C-AldO fusion enzyme is shown using H2O2 
and various AldO substrates at different concentrations. A control reaction using 40 units of catalase, 
myristic acid and OleTJE-HRV3C-AldO confirmed that myristic acid oxidation did not occur in the 
absence of H2O2. Myristic acid product analysis was done using GC/MS. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Substrate Fatty acid 
conversion (%) 
0.5 mM H2O2 87 ± 3
1% glycerol 95 ± 3
3% glycerol 94 ± 4
2 mM sorbitol 93 ± 3
10 mM sorbitol 93 ± 2
2 mM xylitol 91 ± 5
10 mM xylitol 92 ± 3
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Table 3. Myristic acid conversion by OleTJE fusion enzymes and products formed. Reactions were 
performed with 0.5 mM myristic acid using (i) intact OleTJE-HRV3C-AldO, (ii) cleaved OleTJE-HRV3C-
AldO, and (iii) OleTJE-αhelix-AldO at 0.1% and 1% glycerol concentrations. Reactions were stopped 
after 20 minutes. 
 
Enzyme system Glycerol (%) Tridecene 
(µM) 
2-OH myristic 
acid (µM) 
3-OH myristic 
acid (µM) 
% substrate 
conversion 
(i) OleTJE-HRV3C-AldO  1 183 ± 17 0.98 ± 1.40 1.6 ± 0.1 96 ± 1 
0.1 175 ± 6 21 ± 1 93 ± 3.3 81 ± 5 
(ii) OleTJE + AldO 1 137 ± 38 1.0 ± 1.4 1.7 ± 0.1 88 ± 3 
0.1 209 ± 19 22 ± 2 113 ± 7 97 ± 1 
(iii) OleTJE-αhelix-AldO 1 120 ± 2 2.1 ± 0.2 2.4 ± 0.5 98 ± 3 
0.1 118 ± 3 27 ± 2 123 ± 6 93 ± 2 
  
